Showing 321 - 340 of 622 results
Guideline Drug Name
Myqorzo (aficamten) Myqorzo (aficamten)
Naglazyme (galsulfase injection) Naglazyme (galsulfase injection)
Namzaric (memantine/donepezil) Namzaric (memantine and donepezil hydrochloride)
Nasal Steroids Xhance (fluticasone propionate)
Nascobal (cyanocobalamin) Spray- Non Formulary Nascobal (cyanocobalamin) Spray
Natalizumab Products Tysabri (natalizumab), Tyruko (natalizumab-sztn)
Nemluvio (nemolizumab-ilto) Nemluvio (nemolizumab-ilto)
Nerlynx (neratinib) Nerlynx (neratinib)
Neurologic Agents Gralise (gabapentin), Lyrica CR (pregabalin extended-release), Savella (milnacipran), Tonmya (cyclobenzaprine)
New Drug to Market Program - PA New drug to market
New Drug to Market Program - PA New drug to market
Nexavar (sorafenib) Nexavar (sorafenib)
Nexletol (bempedoic acid) and Nexlizet (bempedoic acid-ezetimibe) Nexletol (bempedoic acid), Nexlizet (bempedoic acid-ezetimibe)
Nexviazyme (avalglucosidase alfa-ngpt) Nexviazyme (avalglucosidase alfa-ngpt)
Niktimvo (axatilimab-csfr)- PA, NF Niktimvo (axatilimab-csfr)
Nilotinib Products- PA, NF Danziten (nilotinib tartrate), Nilotinib (nilotinib D-tartrate), Tasigna (nilotinib hydrochloride)
Ninlaro (ixazomib citrate) Ninlaro (ixazomib citrate)
Nitisinone Products - PA, NF Brand Orfadin capsules, Brand Orfadin oral suspension, Generic nitisinone capsules, Harliku (nitisinone), Nityr (nitisinone) tablets
Nocdurna (desmopressin) Nocdurna (desmopressin acetate sublingual tablet)
Non-Essential Drug Program – PA, NF